protoporphyrin ix has been researched along with Experimental Mammary Neoplasms in 8 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, HB | 1 |
| Vani, S | 1 |
| Palanivelu, S | 1 |
| Panchanadham, S | 1 |
| Casas, A | 1 |
| Battah, S | 1 |
| Di Venosa, G | 1 |
| Dobbin, P | 1 |
| Rodriguez, L | 1 |
| Fukuda, H | 1 |
| Batlle, A | 1 |
| MacRobert, AJ | 1 |
| Čunderlíková, B | 1 |
| Vasovič, V | 1 |
| Sieber, F | 1 |
| Furre, T | 1 |
| Borgen, E | 1 |
| Nesland, JM | 1 |
| Peng, Q | 1 |
| Croce, AC | 1 |
| Santamaria, G | 1 |
| De Simone, U | 1 |
| Lucchini, F | 1 |
| Freitas, I | 1 |
| Bottiroli, G | 1 |
| van der Veen, N | 1 |
| van Leengoed, HL | 1 |
| Star, WM | 1 |
| Gibson, SL | 1 |
| Anderson, LT | 1 |
| Havens, JJ | 1 |
| Hilf, R | 1 |
| Bigelow, CE | 1 |
| Mitra, S | 1 |
| Knuechel, R | 1 |
| Foster, TH | 1 |
| Tunstall, RG | 1 |
| Barnett, AA | 1 |
| Schofield, J | 1 |
| Griffiths, J | 1 |
| Vernon, DI | 1 |
| Brown, SB | 1 |
| Roberts, DJ | 1 |
8 other studies available for protoporphyrin ix and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Erythrocyte Protoporphyrin Fluorescence as a Biomarker to Monitor the Anticancer Effect of Semecarpus Anacardium in DMBA Induced Mammary Carcinoma Rat Model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Biomarkers; Carcinogens; Disease Models, An | 2015 |
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Coloring Agents; Dend | 2009 |
Hexaminolevulinate-mediated photodynamic purging of marrow grafts with murine breast carcinoma.
Topics: Aminolevulinic Acid; Animals; Bone Marrow; Bone Marrow Purging; Cell Line, Tumor; Female; Hematopoie | 2011 |
Naturally-occurring porphyrins in a spontaneous-tumour bearing mouse model.
Topics: Animals; Disease Models, Animal; Female; Fluorometry; Iron; Liver; Mammary Neoplasms, Experimental; | 2011 |
In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations.
Topics: Aminolevulinic Acid; Animals; Drug Administration Schedule; Female; Fluorescence; Kinetics; Mammary | 1994 |
Effect of estrogenic perturbations on delta-aminolevulinic acid-induced porphobilinogen deaminase and protoporphyrin IX levels in rat Harderian glands, liver, and R3230AC tumors.
Topics: Aminolevulinic Acid; Animals; Disease Models, Animal; Estrogen Antagonists; Estrogens; Female; Harde | 1999 |
ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids.
Topics: Aminolevulinic Acid; Animals; Dose-Response Relationship, Drug; Esters; Mammary Neoplasms, Experimen | 2001 |
Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Antineoplastic Agents; Carboxylesterase; Ca | 2002 |